Clearity Welcomes Two New Board Members
The Clearity Foundation recently welcomed Sue Ebner and Mike Nall to the Board of Directors, to help advance and expand Clearity's work supporting the ovarian cancer community. Sue Ebner is known for her expertise in sales training, as well as leadership and development. This expertise, coupled with Sue's extensive philanthropic involvement in the San Diego community, will make her a key contributor in helping to expand Clearity's local and national reach. With more than 30 years as a leader in healthcare, Mike Nall brings a wealth of knowledge and expertise in the oncology diagnostic field. Mike's experience will be a valuable addition to Clearity's strategic leadership team focused on bringing the future of precision medicine to women with ovarian cancer today.
About Sue Ebner
Sue is the founder of Ebner Consults which provides sales training and leadership and development training. Sue’s sales training pedagogy is based on the mindful integration of extensive preparation, and the integration of the four behavior styles throughout the five stages of the sales process. Results are invigorating the sales culture, and accelerating and increasing the sales results of the sales team and organization. Her leadership and development trainings focus on essential leadership skills that enhance the effectiveness of empowering leaders.

Prior to launching Ebner Consults, Sue held Sales Executive, Business Development and Account Relationship Manager positions with Mercer, a global consulting leader in talent, health, retirement and investments and a division of MMC, a global $13B, publicly-traded professional services
company. Sue has a MBA and a B.S. in International Relations from the University of San Diego.

She is currently the CFO of the Athena Foundation, and a member of the University of San Diego, School of Leadership and Education Sciences Advisory Board. She has served as a Board member for Athena, Planned Parenthood Pacific Southwest affiliate, The Old Globe Theatre, American Heart Association and the Senior Community Center.
About Mike Nall
 Michael has more than 30 years of healthcare experience and currently serves as President and CEO of Biocept, an innovative San Diego based molecular diagnostics company developing cutting edge technologies known as liquid biopsies. 

Prior to Biocept, Mike helped build Clarient from a start up to one of the largest oncology focused diagnostic companies. While at Clarient, Mike worked with our team at Clearity as one of our first diagnostic testing services providers. Prior to joining Clarient, Mr. Nall served in the diagnostic and medical device industries in various leadership roles for companies including Impath, American Cyanamid, Maquet Surgical, Strato Medical, Horizon Medical Products and Columbia Vital Systems.

Mr. Nall received a Bachelor of Science degree in Business Administration from Central Missouri State University (now known as the University of Central Missouri) and lives here in Southern California with his wife, Janette. 
What's New On The Clearity Blog?
‘This Terrible Disease’: Ovarian Cancer is Deadly, but New Tests, Treatments Start to Emerge

A recent Washington Post article featured Clearity’s Founder, Dr. Laura Shawver, Clearity's Scientific Advisory Board Chair, Dr. Beth Karlan, and Clearity supporter, Andy Laats.

For the past few years, as part of the University of Chicago Pritzker medical school obstetrics-gynecology rotation, med students at an optional lunchtime seminar hear from ovarian cancer survivors who share stories about the shock of diagnosis, painful treatments and constant worries about whether their cancer will come back. Last year, listening to the women’s experiences became a mandatory part of their medical education. The hope is that by humanizing the disease, this relatively rare cancer will be on the radar of a new generation of doctors and will change this common patient narrative: “My doctor didn’t take my symptoms seriously until it was too late.”

A Rising Trend in Cancer Care Targets Physical, Existential Threats Patients Confront

When Tori Geib learned she had terminal metastatic breast cancer in 2016 on the week of her 30th birthday, she was automatically booked to see a palliative care coach at Ohio State University Comprehensive Cancer Center in Columbus.

There, in addition to receiving a targeted therapy pill to slow the spread of the cancer, she was offered a host of services that she says shaped her quality of life for the next three years.